Novel Antifungals and Aspergillus Section Terrei with Potpourri Susceptibility Profiles to Conventional Antifungals

The epidemiology of invasive fungal infections (IFIs) is currently changing, driven by aggressive immunosuppressive therapy, leading to an expanded spectrum of patients at risk of IFIs. Aspergillosis is a leading cause of IFIs, which usually affects immunocompromised patients. There are a limited nu...

Descripción completa

Detalles Bibliográficos
Autores principales: Vahedi-Shahandashti, Roya, Houbraken, Jos, Birch, Mike, Lass-Flörl, Cornelia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10303807/
https://www.ncbi.nlm.nih.gov/pubmed/37367585
http://dx.doi.org/10.3390/jof9060649

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10303807/
https://www.ncbi.nlm.nih.gov/pubmed/37367585
http://dx.doi.org/10.3390/jof9060649

Ejemplares similares